- Home
- PRPH vs MBIO Comparison
PRPH vs MBIO Comparison
Compare PRPH & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- MBIO
- Stock Information
- Founded
- PRPH 1989
- MBIO 2015
- Country
- PRPH United States
- MBIO United States
- Employees
- PRPH N/A
- MBIO N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- MBIO Health Care
- Exchange
- PRPH Nasdaq
- MBIO Nasdaq
- Market Cap
- PRPH 7.8M
- MBIO 7.3M
- IPO Year
- PRPH 1997
- MBIO N/A
- Fundamental
- Price
- PRPH $0.53
- MBIO $2.95
- Analyst Decision
- PRPH Strong Buy
- MBIO Strong Buy
- Analyst Count
- PRPH 1
- MBIO 1
- Target Price
- PRPH $11.00
- MBIO $100.00
- AVG Volume (30 Days)
- PRPH 26.5M
- MBIO 374.6K
- Earning Date
- PRPH 03-14-2025
- MBIO 03-10-2025
- Dividend Yield
- PRPH N/A
- MBIO N/A
- EPS Growth
- PRPH N/A
- MBIO N/A
- EPS
- PRPH N/A
- MBIO N/A
- Revenue
- PRPH $12,753,000.00
- MBIO N/A
- Revenue This Year
- PRPH $36.93
- MBIO N/A
- Revenue Next Year
- PRPH $132.05
- MBIO N/A
- P/E Ratio
- PRPH N/A
- MBIO N/A
- Revenue Growth
- PRPH N/A
- MBIO N/A
- 52 Week Low
- PRPH $0.22
- MBIO $2.40
- 52 Week High
- PRPH $7.48
- MBIO $74.50
- Technical
- Relative Strength Index (RSI)
- PRPH 57.09
- MBIO 32.04
- Support Level
- PRPH $0.28
- MBIO $2.58
- Resistance Level
- PRPH $0.78
- MBIO $2.95
- Average True Range (ATR)
- PRPH 0.10
- MBIO 0.36
- MACD
- PRPH 0.05
- MBIO 0.18
- Stochastic Oscillator
- PRPH 56.07
- MBIO 29.26
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.